WuXi Biologics launches $200m debut borrowing
Chinese pharmaceuticals company WuXi Biologics has launched a debut offshore loan of $200m through sole lead Standard Chartered.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: